Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

Semen Analysis After Proton Therapy for Prostate Cancer

See Locations Near You

Summary

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

- Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

Exclusion Criteria:

Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
History of vasectomy.
Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
Current use of Avodart or Proscar.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

31

Study ID:

NCT01072513

Recruitment Status:

Completed

Sponsor:

University of Florida

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Florida Proton Therapy Institute
Jacksonville Florida, 32206, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

31

Study ID:

NCT01072513

Recruitment Status:

Completed

Sponsor:


University of Florida

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider